Flagship explainer
What drives AKEBIA THERAPEUTICS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$5.3M | FY2025 |
| |
| Income before tax | −$3.7M | FY2025 |
|
| Operating income | $23.5M | FY2025 |
|
| $236M | FY2025 |
| |
| Ending assets | $377M | FY2025 |
|
| Beginning assets | $221M | FY2024 |
|
| $32.6M | FY2025 |
| |
| −$49.2M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001517022-26-000020